#AHA25 Late Breaker iSense diagnosing angiographic obstructive CAD including occlusion MI with AUC of 0.87, specificity 90%, PPV 84%; Freedom from ACS over 30 days with AUC of 0.89, sensitivity 99%, NPV 96%
Over 10M Americans visit the ER yearly fearing a heart attack, but 80% aren’t. They still face hours of tests. RCE’s non-invasive wearable could give results in 3 minutes—no blood draw needed—even in an ambulance, saving time & $$, and focusing critical care on those who need it.
Immediately following the #HRX2024 Pitch Competition, Executive Producer @jenniferavari and Producer @drsuneet talked with 2nd Place Winner, https://t.co/AxI0QQ83Ct, to discuss their winning pitch. See the full interview here #EPeeps ➡️ https://t.co/1ZTsnpg8pC
To learn more about RCE, visit https://t.co/4xy24DlA1N
Winning the #aha23 health tech award is a testament to the hard work, dedication, and passion that drives our team’s commitment to the field of #cardiovascular#medicine and our mission to save human lives by early detection of heart injury.
Congrats to the amazing companies who participated in this year’s Health Tech Competition at #AHA23. @StarJonesEsq said it best: I hope one day there’s a patient on this stage talking about how your solution saved my life. This year’s winners: @PyramesInc@Cardiosense@rce_ai
The votes are in! We’re excited to be finalists in the #AHA23 Center for Health
Technology & Innovation Health Tech Competition!
https://t.co/ddQJN5FA0F
A groundbreaking development in the remote detection of acute MI! Read it in the European Heart Journal - Digital Health https://t.co/YxCIPYgLyM, editorial https://t.co/AiHt7fCwhz and watch ESC TV >March 23rd at 18:00 (CET) https://t.co/vpVM3OXkKc
@escardio@ESC_Journals